THE ANABOLICPROTOCOL
SARMsHigh risk

S-23

Also known as: S-23, S23

The strongest SARM, and the one investigated as a male contraceptive — because it shut down sperm production completely in every animal tested.

Substance family

SARMs

Non-steroidal compounds binding the same androgen receptor as testosterone, but favouring muscle and bone over prostate and hair. The selectivity is real; the suppression of the body's own production is not avoided by it. None is approved anywhere.

Effects on

Which outcomes this substance acts on — descriptive, not a recommendation.

Strain profile

Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.

Liver
medium
Kidneys
minimal
Blood lipids
high
Hematocrit
low
Blood pressure
medium
Hormonal axis
high

Dosing & protocols by goal

Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.

Human clinical data

Medical

Dose

Does not exist

Frequency

Cycle length

S-23 has never completed a human trial. Everything known about it comes from rodent studies. There is no established human dose, safe or otherwise.

Grey market practice

Not a recommendation

Dose

10–30 mg / day reported

Frequency

Split into 2 doses

Cycle length

6–8 weeks reported

These figures come from user reports, not research. Suppression at this level is complete rather than partial, and recovery takes considerably longer than with ostarine or LGD-4033.

Supraphysiological doses carry significant health risks and are not legal without a medical indication. This information serves education and harm reduction, not as a usage recommendation. Accompanying blood work and — where relevant — a post-cycle plan (PCT) are essential. See the disclaimer.

Side effect & countermeasure

Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.

Problem

It was developed to stop sperm production

Countermeasure

This is the central fact and it is usually presented as a footnote. In rodent studies S-23 produced complete, reversible infertility — that was the research goal, as a male contraceptive. Reversibility was shown in animals after discontinuation; it has never been demonstrated in humans, because no human study exists. Anyone who wants children, now or later, is taking an unquantified risk with the one thing that cannot be undone by stopping.

Problem

Total suppression of the body's own production

Countermeasure

Not the partial suppression seen with milder SARMs. LH and FSH go to the floor. A PCT with enclomiphene or clomiphene is not optional here, bloodwork before and after is the only way to know where recovery stands, and the timeline is longer than people expect.

Problem

Severe effect on lipids

Countermeasure

HDL suppression with S-23 is among the harshest in this category, comparable to a strong oral steroid. Omega-3, citrus bergamot and cardio soften the edge; a full lipid panel is what tells you whether the damage is acceptable, and 'acceptable' at these values is often a stretch.

Problem

Rising blood pressure

Countermeasure

Frequently reported and worth measuring rather than feeling. Cardio, sodium and water control first; telmisartan, amlodipine or lisinopril if readings stay high. Persistently high readings are a reason to stop.

Problem

No human data at all

Countermeasure

This is different from 'incompletely studied'. Ostarine reached phase 3 in humans; S-23 never entered human trials. Every dose figure in circulation is somebody's guess extrapolated from rats. There is no basis for saying which dose is dangerous, because nobody has looked.

Overview

S-23 is the most potent SARM in circulation, and the honest description of it is not "strong SARM" but "compound developed to make men temporarily infertile, now sold as a muscle builder."

Both things are true simultaneously. It does have the strongest anabolic effect in this category. It also achieved complete suppression of sperm production in every animal study conducted, which was the point of the research programme.

Mechanism of Action

S-23 binds the androgen receptor with high affinity and, unlike the milder SARMs, with strong systemic activity rather than a pronounced tissue preference. That is where the potency comes from, and it is also why the selectivity that defines the category largely does not apply here.

The suppression follows directly. Strong androgen receptor activation registers in the feedback loop, LH and FSH shut down, and both testosterone production and spermatogenesis stop. In the contraceptive research this was the desired endpoint, achieved reliably, and reversed within weeks of discontinuation — in rats.

Half-life is around 12 hours, which is why twice-daily dosing is the norm among users.

The Contraceptive Point, Properly Stated

This gets mentioned casually in forums as an interesting historical detail. It is not a detail; it is the most reliable thing known about the compound.

The research showed complete infertility during administration and return of fertility afterwards in animals. The reassurance people take from this — that it reverses — rests entirely on rodent data. There is no human study, so nobody can state a recovery rate, a timeline, or whether repeated cycles behave the same as one.

For most other side effects on this site, the worst case is a marker that recovers or a symptom that resolves. Fertility is different in kind: if it does not come back, no protocol fixes it afterwards.

Anyone considering S-23 who might want children should either not use it, or bank sperm beforehand. That is not a dramatic recommendation — it is the only response proportionate to what is actually unknown here.

Where It Sits

Against the rest of the category, S-23 is the strongest, the most suppressive and by far the least studied. Against actual steroids, it offers no advantage: a testosterone base with a well-characterised compound has decades of human data, a known recovery profile, and does not carry an unquantified fertility question.

The argument for SARMs was always that they are milder and more selective. S-23 is neither. What remains is an unapproved research chemical, made without oversight, at doses nobody has validated.

Side Effects & Risks

  • Complete suppression of testosterone and sperm production
  • Severe HDL suppression, rising LDL
  • Elevated blood pressure
  • Elevated liver values
  • Aggression, irritability, sleep disruption
  • Hair loss in those predisposed
  • No manufacturing oversight; contamination and mislabelling are common

Blood Work & Monitoring

  • Total and free testosterone, LH, FSH — before, during and after; expect these at the floor
  • Semen analysis — the measurement that actually matters here, and the one nobody does
  • Lipid profile (LDL, HDL, ApoB)
  • Liver values (ALT, AST, GGT)
  • Blood pressure — measured with a home cuff
  • Estradiol (sensitive assay) — falls along with suppressed testosterone

Legal status by region

Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.

RegionRegulatory status
United StatesNot approved; FDA warning issuedThe FDA has published explicit warnings about SARMs sold as supplements.
EU / UKNo marketing authorisationNeither a medicine nor a supplement — no legal route for human use.
Most other jurisdictionsUnregulated grey areaPossession is legal in many places because no framework covers it. That is not an indication of safety.
Competitive sportProhibited at all timesListed by WADA under S1.2.
All content on this page is for information and harm-reduction purposes only. It is not medical advice, not a recommendation to purchase or use, and does not replace consulting a doctor. Legal status and enforcement vary by country and change; verifying the current rules in your own jurisdiction is your responsibility. For adults 18+ only. See the full disclaimer.